Bone Mineral Density (BMD) in Cemented Versus Cementless Hip Resurfacing
NCT ID: NCT01353326
Last Updated: 2018-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2009-05-15
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement
NCT02576652
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
NCT05228262
Study of Bone Mineral Density and Trabecular Bone Score in Patients With Ankylosing Spondylitis
NCT04392596
Osteoporosis Disease Management Demonstration Project (0000-037)
NCT00139425
Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)
NCT00139438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cementless Hip Resurfacing
Patients randomized into the Cementless Hip Resurfacing Group will have their hip resurfaced with the cementless Cormet / Corin Hip Resurfacing System.
Cormet
Cementless hip resurfacing system
Cemented Hip Resurfacing
Patients randomized into the Cemented Hip Resurfacing Group will have their hip resurfaced with the cemented Conserve Plus Total Resurfacing Hip System.
Conserve
Cemented hip resurfacing system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cormet
Cementless hip resurfacing system
Conserve
Cemented hip resurfacing system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be skeletally mature, as determined by Risser sign or reaching 18 years of age
* Is reasonable expectation that patient will remain available for all FU's scheduled over course of 5 years
Exclusion Criteria
* evidence of active local infection
* neurologic or musculoskeletal disease that may adversely affect gait or weight bearing
* having previously undergone ipsilateral hemi resurfacing, total resurfacing, total bipolar, unipolar or total hip replacement device
* BMI \>35
* neuropathic joints
* severe documented psychiatric disease
* patients requiring structural bone grafts
* documented allergy to cobalt chromium molybdenum
* ipsilateral girdlestone
* sickle cell disease
* significant femoral head or neck deformity, or significant acetabular wall deficiency
* patients with renal failure, defined as serum creatinine greater that 180 µmol/L
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corin
INDUSTRY
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Paul Beaule, MD, FRCSC
Role: PRINCIPAL_INVESTIGATOR
Ottawa Hospital Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ottawa General Hospital
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tice A, Kim P, Dinh L, Ryu JJ, Beaule PE. A randomised controlled trial of cemented and cementless femoral components for metal-on-metal hip resurfacing: a bone mineral density study. Bone Joint J. 2015 Dec;97-B(12):1608-14. doi: 10.1302/0301-620X.97B12.36110.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008058-01H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.